Vulvar pain, itching and burning are common complaints – and often misunderstood. An estimated 10 to 28 percent of all women suffer from vulvodynia in the course of their lives; lichen sclerosus affects around 1.7 percent of the population and is up to 15 times more common than previously diagnosed. Nevertheless, it takes an average of four to seven years for a correct diagnosis to be made. The reason: the overlap between inflammatory dermatoses, functional pain syndromes and oncological precursors requires a systematic clinical assessment, which is often lacking in routine care. The new S3 guideline on lichen sclerosus and a growing body of evidence on the multimodal treatment of vulvodynia offer reliable guidance for the first time.
Autoren
- Tanja Schliebe
Publikation
- GYNÄKOLOGIE PRAXIS
Related Topics
You May Also Like
- Case study
Discoid Lupus Erythematosus in a 38-Year-Old Woman
- Hand and Finger Injuries
Preventing Permanent Functional Limitations
- From an antidiabetic drug to a distinct class of cardiorenal therapies
The Incretin Revolution in Cardiology
- Prostate Cancer
Intracrine and Metabolic Tumor Adaptation Under Androgen Deprivation
- Alopecia areata in children, adolescents, and adults
New Guideline Classifies the Evidence Base for Topical and Systemic Therapies
- Cardiology and Nutrition
Ultra-Processed Foods and Cardiovascular Risk—The New AHA Position
- Actinic keratoses
Targeted Treatment of Multiple AK Lesions—Balancing Efficacy and Convenience
- Obesity: A Multimodal and Interdisciplinary Approach